[1][2] Established in 2017, RDR is headed by Han C. Phan, a sleep specialist and pediatric neurologist.
[7] Clinical trial principal investigators affiliated with RDR include the pediatricians Edward Smith, Renata Shih,[8] Anthony Giordano, and Scott Batchelor.
In addition, each site has an onsite lab for processing lab samples, an affiliated pediatric research home health service, and a research compounding pharmacy with a controlled mixing environment and storage for refrigerated and room-temperature investigational intravenous, intrathecal or oral products, including for gene therapies.
[34][35] RDR relies on central institutional review board (IRB) services to facilitate first subject enrollment within 30-60 days from the beginning of the study date.
It is a member of PPD Site Select, PPD Pediatric Investigator Network, Parexel Site Alliance, and works closely with Syneos Health, IQVIA, Worldwide Clinical Trials, Medpace, and many other CROs.